WO2009001899A1 - 水性組成物 - Google Patents
水性組成物 Download PDFInfo
- Publication number
- WO2009001899A1 WO2009001899A1 PCT/JP2008/061653 JP2008061653W WO2009001899A1 WO 2009001899 A1 WO2009001899 A1 WO 2009001899A1 JP 2008061653 W JP2008061653 W JP 2008061653W WO 2009001899 A1 WO2009001899 A1 WO 2009001899A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- aqueous composition
- medicament
- blended
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/666,765 US20100197811A1 (en) | 2007-06-26 | 2008-06-26 | Aqueous composition |
EP08777618A EP2172224A4 (en) | 2007-06-26 | 2008-06-26 | AQUEOUS COMPOSITION |
CN2008801051111A CN101784287B (zh) | 2007-06-26 | 2008-06-26 | 水性组合物 |
JP2009520637A JP5340149B2 (ja) | 2007-06-26 | 2008-06-26 | 水性組成物 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007167404 | 2007-06-26 | ||
JP2007-167404 | 2007-06-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009001899A1 true WO2009001899A1 (ja) | 2008-12-31 |
Family
ID=40185712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/061653 WO2009001899A1 (ja) | 2007-06-26 | 2008-06-26 | 水性組成物 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20100197811A1 (ja) |
EP (1) | EP2172224A4 (ja) |
JP (1) | JP5340149B2 (ja) |
KR (1) | KR20100031608A (ja) |
CN (1) | CN101784287B (ja) |
WO (1) | WO2009001899A1 (ja) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010254584A (ja) * | 2009-04-21 | 2010-11-11 | Toa Yakuhin Kk | 光安定性に優れたキノロン系抗菌薬含有液体製剤 |
WO2011018800A3 (en) * | 2009-08-13 | 2011-07-21 | Fdc Limited | In-situ gel forming solution for ocular drug delivery |
WO2012026609A1 (ja) * | 2010-08-27 | 2012-03-01 | わかもと製薬株式会社 | 点眼用水性組成物 |
JP2013522283A (ja) * | 2010-03-12 | 2013-06-13 | アラーガン・アンデュストリー・ソシエテ・パール・アクシオン・サンプリフィエ | 皮膚状態を改善するための流体組成物 |
WO2015029717A1 (ja) * | 2013-08-30 | 2015-03-05 | 日油株式会社 | 点眼剤 |
JP2017530195A (ja) * | 2014-10-03 | 2017-10-12 | ラケシス・バイオサイエンシーズ・リミテッド | 神経学的及び神経変性疾患及び障害を処置するための鼻腔投与組成物 |
WO2018199180A1 (ja) | 2017-04-25 | 2018-11-01 | わかもと製薬株式会社 | 熱ゲル化人工涙液 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9004550B2 (en) | 2005-05-08 | 2015-04-14 | Southco, Inc. | Magnetic latch mechanism |
US20230247982A1 (en) * | 2020-07-13 | 2023-08-10 | University Of Cincinnati | Improving Packed Red Blood Cell Storage with a High Viscosity Buffered Storage Solution |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994023750A1 (en) * | 1993-04-16 | 1994-10-27 | Wakamoto Pharmaceutical Co., Ltd. | Reversible, thermally gelling water-base medicinal composition |
JP2729859B2 (ja) | 1993-04-16 | 1998-03-18 | わかもと製薬株式会社 | 可逆性熱ゲル化水性医薬組成物 |
JP2003095924A (ja) | 2001-07-16 | 2003-04-03 | Wakamoto Pharmaceut Co Ltd | 熱ゲル化人工涙液 |
JP2003342197A (ja) * | 2002-03-18 | 2003-12-03 | Wakamoto Pharmaceut Co Ltd | ヒアルロン酸含有熱ゲル化製剤 |
WO2005042026A1 (ja) | 2003-10-31 | 2005-05-12 | Wakamoto Pharmaceutical Co., Ltd. | 可逆性熱ゲル化水性組成物 |
JP2005247804A (ja) * | 2004-03-08 | 2005-09-15 | Zeria Pharmaceut Co Ltd | 点眼剤 |
JP2005343893A (ja) * | 2004-05-07 | 2005-12-15 | Rohto Pharmaceut Co Ltd | 高粘度点眼剤 |
JP2006176501A (ja) * | 2004-11-26 | 2006-07-06 | Taisho Pharmaceut Co Ltd | 眼科用剤 |
JP2006219484A (ja) * | 2005-01-12 | 2006-08-24 | Rohto Pharmaceut Co Ltd | 眼局所適用製剤 |
JP2007500244A (ja) | 2003-06-13 | 2007-01-11 | アルコン,インコーポレイテッド | 2種のポリマーの相乗作用的組み合わせを含む眼科用組成物 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0785780A1 (en) * | 1994-10-10 | 1997-07-30 | Novartis AG | Ophthalmic and aural compositions containing diclofenac potassium |
ZA966579B (en) * | 1995-08-04 | 1998-02-02 | Wakamoto Pharma Co Ltd | O/W emulsion composition for eye drops. |
EP1020194A4 (en) * | 1997-10-01 | 2003-05-21 | Wakamoto Pharma Co Ltd | OIL / WATER EMULSION COMPILATIONS |
US6572849B2 (en) * | 2000-09-20 | 2003-06-03 | Lee Shahinian, Jr. | Self-preserved antibacterial nasal, inhalable, and topical ophthalmic preparations and medications |
US20040028645A1 (en) * | 2001-12-13 | 2004-02-12 | Masood Chowhan | Artificial tear composition adapted to be used with contact lenses |
JP2003183157A (ja) * | 2001-12-19 | 2003-07-03 | Lion Corp | 眼科用組成物 |
US6982079B2 (en) * | 2002-04-26 | 2006-01-03 | Allergan, Inc. | Compositions for treating hyperemia |
FR2860718B1 (fr) * | 2003-10-09 | 2006-02-24 | Jean Pascal Conduzorgues | Nouvelle formulation et ses applications dans le domaines cosmetiques ou pharmaceutiques |
-
2008
- 2008-06-26 KR KR1020107000322A patent/KR20100031608A/ko not_active Application Discontinuation
- 2008-06-26 WO PCT/JP2008/061653 patent/WO2009001899A1/ja active Application Filing
- 2008-06-26 JP JP2009520637A patent/JP5340149B2/ja not_active Expired - Fee Related
- 2008-06-26 US US12/666,765 patent/US20100197811A1/en not_active Abandoned
- 2008-06-26 EP EP08777618A patent/EP2172224A4/en not_active Withdrawn
- 2008-06-26 CN CN2008801051111A patent/CN101784287B/zh not_active Expired - Fee Related
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994023750A1 (en) * | 1993-04-16 | 1994-10-27 | Wakamoto Pharmaceutical Co., Ltd. | Reversible, thermally gelling water-base medicinal composition |
JP2729859B2 (ja) | 1993-04-16 | 1998-03-18 | わかもと製薬株式会社 | 可逆性熱ゲル化水性医薬組成物 |
JP2003095924A (ja) | 2001-07-16 | 2003-04-03 | Wakamoto Pharmaceut Co Ltd | 熱ゲル化人工涙液 |
JP2003342197A (ja) * | 2002-03-18 | 2003-12-03 | Wakamoto Pharmaceut Co Ltd | ヒアルロン酸含有熱ゲル化製剤 |
JP2007500244A (ja) | 2003-06-13 | 2007-01-11 | アルコン,インコーポレイテッド | 2種のポリマーの相乗作用的組み合わせを含む眼科用組成物 |
WO2005042026A1 (ja) | 2003-10-31 | 2005-05-12 | Wakamoto Pharmaceutical Co., Ltd. | 可逆性熱ゲル化水性組成物 |
JP2005247804A (ja) * | 2004-03-08 | 2005-09-15 | Zeria Pharmaceut Co Ltd | 点眼剤 |
JP2005343893A (ja) * | 2004-05-07 | 2005-12-15 | Rohto Pharmaceut Co Ltd | 高粘度点眼剤 |
JP2006176501A (ja) * | 2004-11-26 | 2006-07-06 | Taisho Pharmaceut Co Ltd | 眼科用剤 |
JP2006219484A (ja) * | 2005-01-12 | 2006-08-24 | Rohto Pharmaceut Co Ltd | 眼局所適用製剤 |
Non-Patent Citations (1)
Title |
---|
See also references of EP2172224A4 |
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010254584A (ja) * | 2009-04-21 | 2010-11-11 | Toa Yakuhin Kk | 光安定性に優れたキノロン系抗菌薬含有液体製剤 |
WO2011018800A3 (en) * | 2009-08-13 | 2011-07-21 | Fdc Limited | In-situ gel forming solution for ocular drug delivery |
JP2013522283A (ja) * | 2010-03-12 | 2013-06-13 | アラーガン・アンデュストリー・ソシエテ・パール・アクシオン・サンプリフィエ | 皮膚状態を改善するための流体組成物 |
US9585821B2 (en) | 2010-03-12 | 2017-03-07 | Allergan Industrie Sas | Methods for making compositions for improving skin conditions |
US9125840B2 (en) | 2010-03-12 | 2015-09-08 | Allergan Industrie Sas | Methods for improving skin conditions |
JP2015164948A (ja) * | 2010-03-12 | 2015-09-17 | アラーガン・アンデュストリー・ソシエテ・パール・アクシオン・サンプリフィエAllergan Industrie Sas | 皮膚状態を改善するための流体組成物 |
WO2012026609A1 (ja) * | 2010-08-27 | 2012-03-01 | わかもと製薬株式会社 | 点眼用水性組成物 |
CN103079595A (zh) * | 2010-08-27 | 2013-05-01 | 若素制药株式会社 | 滴眼用水性组合物 |
CN103079595B (zh) * | 2010-08-27 | 2015-11-25 | 若素制药株式会社 | 滴眼用水性组合物 |
JP5870459B2 (ja) * | 2010-08-27 | 2016-03-01 | わかもと製薬株式会社 | 点眼用水性組成物 |
JPWO2015029717A1 (ja) * | 2013-08-30 | 2017-03-02 | 日油株式会社 | 点眼剤 |
WO2015029717A1 (ja) * | 2013-08-30 | 2015-03-05 | 日油株式会社 | 点眼剤 |
AU2014313287B2 (en) * | 2013-08-30 | 2019-05-23 | Nof Corporation | Ophthalmic solution |
US10471171B2 (en) | 2013-08-30 | 2019-11-12 | Nof Corporation | Ophthalmic solution |
JP2017530195A (ja) * | 2014-10-03 | 2017-10-12 | ラケシス・バイオサイエンシーズ・リミテッド | 神経学的及び神経変性疾患及び障害を処置するための鼻腔投与組成物 |
JP7357571B2 (ja) | 2014-10-03 | 2023-10-06 | ラケシス・バイオサイエンシーズ・リミテッド | 神経学的及び神経変性疾患及び障害を処置するための鼻腔投与組成物 |
WO2018199180A1 (ja) | 2017-04-25 | 2018-11-01 | わかもと製薬株式会社 | 熱ゲル化人工涙液 |
JP6473274B1 (ja) * | 2017-04-25 | 2019-02-20 | わかもと製薬株式会社 | 熱ゲル化人工涙液 |
KR20190110624A (ko) | 2017-04-25 | 2019-09-30 | 와카모토 세이야꾸 가부시끼가이샤 | 열겔화 인공 누액 |
RU2710366C1 (ru) * | 2017-04-25 | 2019-12-26 | Вакамото Фармасьютикал Ко., Лтд. | Термочувствительная гелеобразующая искусственная слеза |
US10532026B2 (en) | 2017-04-25 | 2020-01-14 | Wakamoto Pharmaceutical Co., Ltd. | Thermo-responsive gelling artificial lacrima |
KR20200020999A (ko) | 2017-04-25 | 2020-02-26 | 와카모토 세이야꾸 가부시끼가이샤 | 열겔화 인공 누액 |
US11096889B2 (en) | 2017-04-25 | 2021-08-24 | Wakamoto Pharmaceutical Co., Ltd. | Thermo-responsive gelling artificial lacrima |
Also Published As
Publication number | Publication date |
---|---|
JPWO2009001899A1 (ja) | 2010-08-26 |
CN101784287B (zh) | 2013-04-24 |
KR20100031608A (ko) | 2010-03-23 |
EP2172224A1 (en) | 2010-04-07 |
JP5340149B2 (ja) | 2013-11-13 |
EP2172224A4 (en) | 2013-01-16 |
CN101784287A (zh) | 2010-07-21 |
US20100197811A1 (en) | 2010-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009001899A1 (ja) | 水性組成物 | |
CL2013000768A1 (es) | Composicion farmaceutica que comprende un compuesto derivado de (6s)-6-(2-hidroxi-2-metilpropil)-6-fenil-3-{(1s)-1-[4-(2-oxo-1,2-dihidropiridin-4-il)fenil]etil}-1,3-oxazin-2-ona y un segundo agente terapéutico; y su uso para prevenir o retrasar un trastorno asociado a diabetes mellitus 2 o tolerancia alterada a la glucosa. | |
EA200901155A1 (ru) | Модуляторы фармакокинетических свойств терапевтических препаратов (варианты) и их использование в терапии | |
CL2007001972A1 (es) | Ester isopropilico del acido 4-[6-(6-metanosulfonil-2-metilpiridin-3-ilamino)-5-metilpirimidin-4-iloxi]piperidin-1-carboxilico, moduladores del metabolismo; composicion farmaceutica; y su uso para tratar trastornos metabolicos. | |
DE602007002295D1 (de) | Arzneimittelabgabevorrichtung | |
BRPI0806531A2 (pt) | Composto, composição farmacêutica, agente terapêutico, e, uso do composto. | |
HRP20090077B1 (hr) | Modulatori farmakokinetičkih svojstava terapeutika | |
WO2008021795A3 (en) | Flowable carrier matrix | |
CL2012003350A1 (es) | Composicion farmaceutica inyectable de liberacion controlada que comprende risperidona, un copolimero de acido lactico y glicolico, un disolvente miscible en agua, una viscosidad y una relacion de masas de disolvente/farmaco y de farmaco/polimero especificas; kit farmaceutico; y uso para tratar esquizofrenia o trastornos bipolares. | |
MX2010013020A (es) | Metodos y composiciones para trastornos del sueño y otros trastornos. | |
HK1128471A1 (en) | Heterocyclic non-nucleoside compounds, their preparation, pharmaceutical composition and their use as antiviral agents | |
ECSP088239A (es) | Composición de liberación de fármaco sostenida | |
WO2005069831A3 (en) | Injector for viscous materials | |
EA200700340A1 (ru) | Мультичастицы | |
NZ593301A (en) | Drive mechanism for a medication delivery device with a stop member preventing rotation of the drive member during dose setting | |
ES2445846R1 (es) | Una composición de combinación farmacéutica y su uso para preparar un medicamento destinado al tatamiento de la diabetes de tipo l y los trastornos metabólicos | |
BRPI0820308B8 (pt) | composição farmacêutica compreendendo oxi-hidróxido de ferro em alta carga, seus usos e seus processos de preparação, e comprimido | |
WO2009091576A3 (en) | Parenteral formulations of dopamine agonists | |
WO2007098128A3 (en) | Phenylephrine-containing liquid formulations | |
MX2010004373A (es) | Materiales miscibles en agua no acuosos como vehiculos para suministro de farmacos. | |
MY146654A (en) | Nicotine-carrier vaccine formulation | |
BR112015017246A8 (pt) | composição farmacêutica aquosa, seu uso e seringa | |
WO2007111945A3 (en) | Method for management of diarrhea | |
WO2009067856A8 (zh) | 组蛋白去乙酰化酶抑制剂及其制备和用途 | |
WO2011019326A3 (en) | Solubility and stability enchancing pharmaceutical formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200880105111.1 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08777618 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12666765 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009520637 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 20107000322 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008777618 Country of ref document: EP |